• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆miR-10a:一种潜在的冠状动脉疾病生物标志物。

Plasma miR-10a: A Potential Biomarker for Coronary Artery Disease.

作者信息

Luo Liyun, Chen Bairong, Li Songbiao, Wei Xiaoliang, Liu Tianmin, Huang Yin, Lin Xiufang

机构信息

Department of Cardiology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong 519000, China.

出版信息

Dis Markers. 2016;2016:3841927. doi: 10.1155/2016/3841927. Epub 2016 May 22.

DOI:10.1155/2016/3841927
PMID:27313333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4893451/
Abstract

Aims. MicroRNAs (miRNAs) are involved in the pathogenesis of coronary artery disease (CAD). The objective of this study is to determine plasma levels of miR-10a in CAD and analyze its association with the severity of CAD. Materials and Methods. Plasma miR-10a levels in 60 CAD patients including stable angina pectoris (SAP) (n = 29), unstable angina pectoris (UAP) or non-ST elevation myocardial infarction (MI) (NSTEMI) (n = 17), or ST elevation MI (STEMI) (n = 14) and 20 non-CAD subjects were assessed by real-time polymerase chain reaction (qRT-PCR), and associations of miR-10a levels with risk factors of CAD and its severity were analyzed. Results. The qRT-PCR results showed that plasma miR-10a levels were decreased in CAD patients, and CAD with high SYNTAX scores or STEMI was significantly associated with lower miR-10a levels. Conclusions. Lower plasma miR-10a levels were negatively associated with the presence as well as severity of CAD, and plasma miR-10a can act as a potential biomarker for estimating the presence and severity of CAD.

摘要

目的。微小RNA(miRNA)参与冠状动脉疾病(CAD)的发病机制。本研究的目的是测定CAD患者血浆中miR-10a的水平,并分析其与CAD严重程度的关联。材料与方法。通过实时聚合酶链反应(qRT-PCR)评估60例CAD患者(包括稳定型心绞痛(SAP)患者29例、不稳定型心绞痛(UAP)或非ST段抬高型心肌梗死(MI)(NSTEMI)患者17例、ST段抬高型心肌梗死(STEMI)患者14例)及20例非CAD受试者血浆中miR-10a的水平,并分析miR-10a水平与CAD危险因素及其严重程度的关联。结果。qRT-PCR结果显示,CAD患者血浆miR-10a水平降低,且SYNTAX评分高的CAD或STEMI与较低的miR-10a水平显著相关。结论。血浆miR-10a水平降低与CAD的存在及其严重程度呈负相关,血浆miR-10a可作为评估CAD存在及严重程度的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4577/4893451/9b7d4a2f448c/DM2016-3841927.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4577/4893451/36a82876eb17/DM2016-3841927.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4577/4893451/12cff0ea9073/DM2016-3841927.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4577/4893451/6fb46cd689d3/DM2016-3841927.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4577/4893451/9b7d4a2f448c/DM2016-3841927.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4577/4893451/36a82876eb17/DM2016-3841927.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4577/4893451/12cff0ea9073/DM2016-3841927.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4577/4893451/6fb46cd689d3/DM2016-3841927.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4577/4893451/9b7d4a2f448c/DM2016-3841927.004.jpg

相似文献

1
Plasma miR-10a: A Potential Biomarker for Coronary Artery Disease.血浆miR-10a:一种潜在的冠状动脉疾病生物标志物。
Dis Markers. 2016;2016:3841927. doi: 10.1155/2016/3841927. Epub 2016 May 22.
2
Altered Plasma miR-144 as a Novel Biomarker for Coronary Artery Disease.血浆中miR-144改变作为冠状动脉疾病的新型生物标志物
Ann Clin Lab Sci. 2018 Jul;48(4):440-445.
3
Plasma MicroRNA-126-5p is Associated with the Complexity and Severity of Coronary Artery Disease in Patients with Stable Angina Pectoris.血浆微小RNA-126-5p与稳定型心绞痛患者冠状动脉疾病的复杂性和严重程度相关。
Cell Physiol Biochem. 2016;39(3):837-46. doi: 10.1159/000447794. Epub 2016 Aug 9.
4
Expression of miR-126 and its potential function in coronary artery disease.miR-126的表达及其在冠状动脉疾病中的潜在功能
Afr Health Sci. 2017 Jun;17(2):474-480. doi: 10.4314/ahs.v17i2.22.
5
Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.血浆 vaspin 浓度在急性冠状动脉综合征中降低,但在无冠状动脉病变的患者中不变。
Clin Biochem. 2013 Oct;46(15):1520-5. doi: 10.1016/j.clinbiochem.2013.06.028. Epub 2013 Jul 11.
6
Circulating Extracellular miRNA Analysis in Patients with Stable CAD and Acute Coronary Syndromes.稳定型 CAD 和急性冠状动脉综合征患者循环细胞外 miRNA 分析。
Biomolecules. 2021 Jun 29;11(7):962. doi: 10.3390/biom11070962.
7
Alteration of circulating miRNAs during myocardial infarction and association with lipid levels.心肌梗死后循环 miRNA 的变化及其与脂质水平的关系。
Lab Med. 2024 May 2;55(3):361-372. doi: 10.1093/labmed/lmad094.
8
MiR-23a Regulates the Vasculogenesis of Coronary Artery Disease by Targeting Epidermal Growth Factor Receptor.微小RNA-23a通过靶向表皮生长因子受体调控冠状动脉疾病的血管生成
Cardiovasc Ther. 2016 Aug;34(4):199-208. doi: 10.1111/1755-5922.12187.
9
miR-22 contributes to the pathogenesis of patients with coronary artery disease by targeting MCP-1: An observational study.通过靶向单核细胞趋化蛋白-1,miR-22在冠状动脉疾病患者发病机制中起作用:一项观察性研究。
Medicine (Baltimore). 2016 Aug;95(33):e4418. doi: 10.1097/MD.0000000000004418.
10
Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.外周循环 CD14+单核细胞中基质金属蛋白酶 9/金属蛋白酶组织抑制剂 1 比值与冠状动脉疾病进展的关系。
Am J Cardiol. 2010 Feb 15;105(4):429-34. doi: 10.1016/j.amjcard.2009.10.013. Epub 2010 Jan 5.

引用本文的文献

1
Cellular Phenotypic Transformation During Atherosclerosis: The Potential Role of miRNAs as Biomarkers.动脉粥样硬化过程中的细胞表型转化:微小RNA作为生物标志物的潜在作用
Int J Mol Sci. 2025 Feb 27;26(5):2083. doi: 10.3390/ijms26052083.
2
Non-coding RNA mediates endoplasmic reticulum stress-induced apoptosis in heart disease.非编码RNA介导内质网应激诱导的心脏病细胞凋亡。
Heliyon. 2023 May 13;9(5):e16246. doi: 10.1016/j.heliyon.2023.e16246. eCollection 2023 May.
3
microRNA-363-3p reduces endothelial cell inflammatory responses in coronary heart disease via inactivation of the -dependent p38 MAPK axis.

本文引用的文献

1
Isolation and enrichment of circulating biomarkers for cancer screening, detection, and diagnostics.用于癌症筛查、检测和诊断的循环生物标志物的分离与富集。
Analyst. 2016 Jan 21;141(2):382-92. doi: 10.1039/c5an01762a.
2
Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases.循环微小RNA:用于诊断心脑血管疾病的潜在及新兴生物标志物
Biomed Res Int. 2015;2015:730535. doi: 10.1155/2015/730535. Epub 2015 May 28.
3
Epigenetics in autoimmune diseases: Pathogenesis and prospects for therapy.
microRNA-363-3p 通过失活 - 依赖性 p38 MAPK 轴减少冠心病内皮细胞炎症反应。
Aging (Albany NY). 2021 Mar 19;13(8):11061-11082. doi: 10.18632/aging.202721.
4
, , , and Polymorphisms are Associated with Ischemic Stroke Susceptibility and Post-Stroke Mortality.[具体基因名称]、[具体基因名称]、[具体基因名称]和[具体基因名称]多态性与缺血性中风易感性及中风后死亡率相关。 (你提供的原文中基因名称缺失,需补充完整才能准确翻译,这里是根据格式要求给出的示例翻译)
Life (Basel). 2020 Nov 25;10(12):309. doi: 10.3390/life10120309.
5
Overexpression of MicroRNA-16 Alleviates Atherosclerosis by Inhibition of Inflammatory Pathways.MicroRNA-16 的过表达通过抑制炎症通路缓解动脉粥样硬化。
Biomed Res Int. 2020 Jul 21;2020:8504238. doi: 10.1155/2020/8504238. eCollection 2020.
6
Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets.氧化应激与内皮功能障碍的新发病机制:潜在的诊断生物标志物和治疗靶点
J Clin Med. 2020 Jun 25;9(6):1995. doi: 10.3390/jcm9061995.
7
DNA Methylation Trajectories During Pregnancy.孕期DNA甲基化轨迹
Epigenet Insights. 2019 Aug 13;12:2516865719867090. doi: 10.1177/2516865719867090. eCollection 2019.
8
MicroRNAs or Long Noncoding RNAs in Diagnosis and Prognosis of Coronary Artery Disease.微小RNA或长链非编码RNA在冠状动脉疾病诊断和预后中的作用
Aging Dis. 2019 Apr 1;10(2):353-366. doi: 10.14336/AD.2018.0617. eCollection 2019 Apr.
9
Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation.miR-10a 介导的 TGF-β1/Smads 信号转导的调节影响心房颤动诱导的心肌纤维化和心肌成纤维细胞增殖。
Biosci Rep. 2019 Feb 8;39(2). doi: 10.1042/BSR20181931. Print 2019 Feb 28.
10
Inhibition of miR-10a-5p suppresses cholangiocarcinoma cell growth through downregulation of Akt pathway.抑制miR-10a-5p通过下调Akt信号通路抑制胆管癌细胞生长。
Onco Targets Ther. 2018 Oct 15;11:6981-6994. doi: 10.2147/OTT.S182225. eCollection 2018.
自身免疫性疾病中的表观遗传学:发病机制与治疗前景。
Autoimmun Rev. 2015 Oct;14(10):854-63. doi: 10.1016/j.autrev.2015.05.008. Epub 2015 May 27.
4
miRNAs in atherosclerotic plaque initiation, progression, and rupture.微小RNA在动脉粥样硬化斑块的起始、进展和破裂过程中的作用
Trends Mol Med. 2015 May;21(5):307-18. doi: 10.1016/j.molmed.2015.02.003. Epub 2015 Mar 11.
5
Heart disease and stroke statistics--2015 update: a report from the American Heart Association.《2015年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2015 Jan 27;131(4):e29-322. doi: 10.1161/CIR.0000000000000152. Epub 2014 Dec 17.
6
Pathologic function and therapeutic potential of exosomes in cardiovascular disease.外泌体在心血管疾病中的病理功能及治疗潜力
Biochim Biophys Acta. 2015 Jan;1852(1):1-11. doi: 10.1016/j.bbadis.2014.10.008. Epub 2014 Oct 16.
7
Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction.循环 microRNAs 作为急性心肌梗死的新型敏感生物标志物。
Clin Biochem. 2012 Jul;45(10-11):727-32. doi: 10.1016/j.clinbiochem.2012.04.013.
8
MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro.MicroRNA-10a 在体内和体外调节易损动脉粥样硬化内皮的促炎表型。
Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13450-5. doi: 10.1073/pnas.1002120107. Epub 2010 Jul 12.
9
Population trends in the incidence and outcomes of acute myocardial infarction.人口趋势对急性心肌梗死发病率和结局的影响。
N Engl J Med. 2010 Jun 10;362(23):2155-65. doi: 10.1056/NEJMoa0908610.
10
Inflammation and atherosclerosis.炎症与动脉粥样硬化。
Circ Res. 2007 Oct 12;101(8):750-1. doi: 10.1161/CIRCRESAHA.107.162487.